Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18784335 | 1.00 | ALDH1A1 (0.42) | ALDH1A1CNR1CNR2TRPV1 | |
| SCHEMBL18800953 | 1.00 | ALDH1A1 (0.42) | ALDH1A1CNR1CNR2TRPV1 | |
| SCHEMBL18800952 | 0.97 | TRPV1 (0.41) | ALDH1A1CNR1CNR2TRPV1 | |
| SCHEMBL18784264 | 0.94 | ALDH1A1 (0.42) | ALDH1A1CNR1CNR2TRPV1 | |
| SCHEMBL18784597 | 0.94 | ALDH1A1 (0.42) | ALDH1A1CNR1CNR2TRPV1 | |
| SCHEMBL18784288 | 0.88 | TRPV1 (0.46) | ALDH1A1TRPV1 | |
| SCHEMBL18784289 | 0.88 | TRPV1 (0.46) | ALDH1A1TRPV1 | |
| SCHEMBL18800993 | 0.87 | ALDH1A1 (0.43) | ALDH1A1CNR1CNR2TRPV1 | |
| SCHEMBL22423619 | 0.87 | ALDH1A1 (0.36) | ALDH1A1CNR1CNR2 | |
| SCHEMBL22423629 | 0.86 | TRPV1 (0.44) | ALDH1A1TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3162794-B1 | ALKYL SUBSTITUTED AZETIDINES AS CATIONIC LIPID | KYOWA KIRIN CO LTD (JP) | 2020-09-16 | — | — | EP | disclosed |
| US-20170224619-A1 | CATIONIC LIPID | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2017-08-10 | — | — | US | disclosed |
| EP-3162794-A1 | CATIONIC LIPID | Kyowa Hakko Kirin Co., Ltd. (JP) | 2017-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170224619-A1 | CATIONIC LIPID | NPC1L1, NPC1, SGMS1 | ALDH1A1 3134/4885CNR1 719/4885CNR2 1192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.